"Name","Gene.s.","Protein.change","Condition.s.","Clinical.significance..Last.reviewed.","Review.status","Accession","GRCh37Chromosome","GRCh37Location","GRCh38Chromosome","GRCh38Location","VariationID","AlleleID.s.","dbSNP.ID","Canonical.SPDI"
"0","0","0","0","0","0","0","0","0","0","0",0,"0","0","0"
"NM_000702.4(ATP1A2):c.2659T>C (p.Trp887Arg)","ATP1A2","W887R","Familial hemiplegic migraine|Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Apr 22, 2021)","no assertion criteria provided","VCV000012918","1","160106455","1","160136665",12918,"27957","rs28933399","NC_000001.11:160136664:T:C"
"NM_000702.4(ATP1A2):c.2192T>C (p.Met731Thr)","ATP1A2","M731T","Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Jan 13, 2012)","no assertion criteria provided","VCV000012919","1","160105300","1","160135510",12919,"27958","rs28933400","NC_000001.11:160135509:T:C"
"NM_000069.3(CACNA1S):c.3716G>A (p.Arg1239His)","CACNA1S","R1239H","Malignant hyperthermia, susceptibility to, 5|Hypokalemic periodic paralysis 1|not provided|Hypokalemic periodic paralysis 1","Pathogenic(Last reviewed: Sep 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017623","1","201022666","1","201053538",17623,"32662","rs28930068","NC_000001.11:201053537:C:T"
"NM_000157.3(GBA):c.1448T>C","GBA|LOC106627981","L483P, L396P, L434P","not provided|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Parkinson disease, late-onset|Gaucher disease|Dementia, Lewy body, susceptibility to|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Thoracolumbar scoliosis|Resting tremor|Parkinsonism|Hypomimic face|Movement disorder","Pathogenic, risk factor(Last reviewed: Jun 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004288","1","155205043","1","155235252",4288,"19327","rs421016","NC_000001.11:155235251:A:G"
"NM_024009.3(GJB3):c.101T>C (p.Leu34Pro)","GJB3","L34P","Erythrokeratodermia variabilis et progressiva 1","Pathogenic(Last reviewed: May 15, 2002)","no assertion criteria provided","VCV000006491","1","35250464","1","34784863",6491,"21530","rs28937583","NC_000001.11:34784862:T:C"
"NM_001122764.3(PPOX):c.767C>G (p.Pro256Arg)","PPOX","P256R, P120R, P223R, P94R","not provided|Variegate porphyria|Variegate porphyria, homozygous","Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)","criteria provided, conflicting interpretations","VCV000008704","1","161138933","1","161169143",8704,"23743","rs12735723","NC_000001.11:161169142:C:G"
"NM_000350.3(ABCA4):c.2828G>A (p.Arg943Gln)","ABCA4","R943Q","not provided|not specified|MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|none provided|Stargardt disease|Macular degeneration|Stargardt disease 1|ABCA4-Related Disorders|Stargardt Disease, Recessive|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive","Benign/Likely benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000007913","1","94512565","1","94047009",7913,"22952","rs1801581","NC_000001.11:94047008:C:T"
"NC_000001.11:g.198807802C>A","","","Acute myeloid leukemia with maturation","Pathogenic","no assertion criteria provided","VCV000427752","1","198776931","1","198807802",427752,"417641","rs9660525","NC_000001.11:198807801:C:A"
"NM_000350.3(ABCA4):c.3386G>T (p.Arg1129Leu)","ABCA4","R1129L","Retinal dystrophy|not provided|Stargardt disease 1|Stargardt disease 1|Cone-rod dystrophy 3|Age-related macular degeneration 2|Retinitis pigmentosa 19|Age-related macular degeneration 2","Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000099224","1","94506901","1","94041345",99224,"105113","rs1801269","NC_000001.11:94041344:C:A"
"NM_000157.4(GBA):c.1448T>G (p.Leu483Arg)","GBA|LOC106627981","L483R, L434R, L396R","not provided|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease","Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093449","1","155205043","1","155235252",93449,"99356","rs421016","NC_000001.11:155235251:A:C"
"NM_000157.4(GBA):c.721G>A (p.Gly241Arg)","GBA|LOC106627981","G241R, G154R, G192R","Gaucher disease|not provided|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease type I","Pathogenic(Last reviewed: Oct 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093459","1","155207965","1","155238174",93459,"99364","rs409652","NC_000001.11:155238173:C:T"
"NM_000350.3(ABCA4):c.3377T>C (p.Leu1126Pro)","ABCA4","L1126P","Stargardt disease 1","Likely pathogenic(Last reviewed: Jan 1, 2016)","criteria provided, single submitter","VCV000236101","1","94506910","1","94041354",236101,"237679","rs1047376","NC_000001.11:94041353:A:G"
"NM_014625.3(NPHS2):c.-51G>T","NPHS2","","Idiopathic nephrotic syndrome|not provided|not specified","Benign(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000225144","1","179545050","1","179575915",225144,"227036","rs12406197","NC_000001.11:179575914:C:A"
"NM_001008212.2(OPTN):c.293T>A (p.Met98Lys)","OPTN|LOC108903148","M98K","Primary open angle glaucoma|Glaucoma, normal tension, susceptibility to|not specified|Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12|none provided|Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, e","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000007099","10","13152400","10","13110400",7099,"22138","rs11258194","NC_000010.11:13110399:T:A"
"CYP2C19*4A/*10","CYP2C19","P227L","Voriconazole response|Sertraline response|Escitalopram response|Citalopram response","drug response","practice guideline","VCV000633981","10","96541615","10","94781858",633981,"47951","rs6413438","NC_000010.11:94781857:C:T"
"NM_000360.4(TH):c.733A>C (p.Thr245Pro)","TH","T276P, T245P, T272P","Autosomal recessive DOPA responsive dystonia","Pathogenic(Last reviewed: Jan 1, 2000)","no assertion criteria provided","VCV000012329","11","2188225","11","2166995",12329,"27368","rs28934581","NC_000011.10:2166994:T:G"
"NM_000260.4(MYO7A):c.47T>C (p.Leu16Ser)","MYO7A","L16S, L5S","Usher syndrome type 1|Usher syndrome, type 1B|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|not provided|none provided|not specified","Benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000043258","11","76853783","11","77142737",43258,"52428","rs1052030","NC_000011.10:77142736:T:C"
"NM_000244.3(MEN1):c.76G>A (p.Glu26Lys)","MEN1","E26K","not provided|Multiple endocrine neoplasia, type 1|Parathyroid adenoma, somatic","Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2019)","criteria provided, conflicting interpretations","VCV000016689","11","64577506","11","64810034",16689,"31728","rs28931612","NC_000011.10:64810033:C:T"
"NM_003356.4(UCP3):c.304G>A (p.Val102Ile)","UCP3","V102I","UCP3 POLYMORPHISM G/A|Obesity, severe, and type II diabetes","Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 1998)","no assertion criteria provided","VCV000007576","11","73717247","11","74006202",7576,"22615","rs2229707","NC_000011.10:74006201:C:T"
"NM_000525.3(KCNJ11):c.440T>C (p.Leu147Pro)","KCNJ11","L147P, L60P","Hyperinsulinemic hypoglycemia, familial, 2","Pathogenic(Last reviewed: Mar 16, 2015)","criteria provided, single submitter","VCV000008665","11","17409199","11","17387652",8665,"23704","rs28936678","NC_000011.10:17387651:A:G"
"NM_000260.4(MYO7A):c.47T>A (p.Leu16Ter)","MYO7A","L16*, L5*","not provided|Usher syndrome type 1|Deafness, autosomal recessive 2","Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)","criteria provided, multiple submitters, no conflicts","VCV000549974","11","76853783","11","77142737",549974,"546385","rs1052030","NC_000011.10:77142736:T:A"
"NM_001065.4(TNFRSF1A):c.362G>C (p.Arg121Pro)","TNFRSF1A","R92P, R121P, R13P","TNF receptor-associated periodic fever syndrome (TRAPS)","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000012341","12","6442643","12","6333477",12341,"27380","rs4149584","NC_000012.12:6333476:C:G"
"NM_000486.5(AQP2):c.170A>C (p.Gln57Pro)","AQP2","Q57P","not provided|Nephrogenic diabetes insipidus, autosomal","Pathogenic(Last reviewed: Feb 5, 2019)","criteria provided, single submitter","VCV000017842","12","50344783","12","49951000",17842,"32881","rs28931580","NC_000012.12:49950999:A:C"
"NM_000017.4(ACADS):c.511C>T (p.Arg171Trp)","ACADS","R171W","not provided|Deficiency of butyryl-CoA dehydrogenase","Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2020)","criteria provided, conflicting interpretations","VCV000003830","12","121175678","12","120737875",3830,"18869","rs1800556","NC_000012.12:120737874:C:T"
"NM_000277.3(PAH):c.782G>A (p.Arg261Gln)","PAH","R261Q","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000000582","12","103246653","12","102852875",582,"15621","rs5030849","NC_000012.12:102852874:C:T"
"NM_000277.3(PAH):c.842+1G>A","PAH","","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000000599","12","103246592","12","102852814",599,"15638","rs5030852","NC_000012.12:102852813:C:T"
"NM_000552.5(VWF):c.4196G>A","VWF","R1399H","Abnormality of coagulation|not provided|VON WILLEBRAND FACTOR POLYMORPHISM|von Willebrand disease type 1|none provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2019)","criteria provided, conflicting interpretations","VCV000000293","12","6128388","12","6019222",293,"15332","rs1800382","NC_000012.12:6019221:C:T"
"NM_002150.3(HPD):c.97= (p.Thr33=)","HPD","","Tyrosinemia type 3|Hawkinsinuria|Hawkinsinuria","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000001577","12","122295335","12","121857429",1577,"16616","rs1154510","NC_000012.12:121857428:T:T"
"NM_000785.4(CYP27B1):c.1004G>C (p.Arg335Pro)","CYP27B1","R335P","Vitamin D-dependent rickets type 1A","Pathogenic(Last reviewed: Mar 5, 1998)","no assertion criteria provided","VCV000001660","12","58158293","12","57764510",1660,"16699","rs28934606","NC_000012.12:57764509:C:G"
"NM_000020.2(ACVRL1):c.1127T>G (p.Met376Arg)","ACVRL1","M376R","Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic(Last reviewed: Jun 1, 1996)","no assertion criteria provided","VCV000008244","12","52309898","12","51916114",8244,"23283","rs28936399","NC_000012.12:51916113:T:G"
"NM_000020.2(ACVRL1):c.1120C>T (p.Arg374Trp)","ACVRL1","R374W","not provided|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008249","12","52309891","12","51916107",8249,"23288","rs28936401","NC_000012.12:51916106:C:T"
"NM_002905.4(RDH5):c.208C>T (p.Arg70Trp)","RDH5|BLOC1S1-RDH5","R70W","not provided|Retinitis pigmentosa|Pigmentary retinal dystrophy","Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2020)","criteria provided, conflicting interpretations","VCV000636196","12","56115176","12","55721392",636196,"623998","rs1058635","NC_000012.12:55721391:C:T"
"NM_002150.3(HPD):c.97A>G (p.Thr33Ala)","HPD","T33A","Hawkinsinuria|Tyrosinemia type 3|Hawkinsinuria","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000802899","12","122295335","12","121857429",802899,"791201","rs1154510","NC_000012.12:121857428:T:C"
"NM_000020.3(ACVRL1):c.1120C>A (p.Arg374=)","ACVRL1","","not provided","Uncertain significance(Last reviewed: Sep 1, 2018)","criteria provided, single submitter","VCV000806892","12","52309891","12","51916107",806892,"796796","rs28936401","NC_000012.12:51916106:C:A"
"NM_000277.3(PAH):c.782G>T (p.Arg261Leu)","PAH","R261L","Phenylketonuria","Uncertain significance(Last reviewed: Nov 8, 2019)","reviewed by expert panel","VCV000585208","12","103246653","12","102852875",585208,"576255","rs5030849","NC_000012.12:102852874:C:A"
"NM_000277.3(PAH):c.782G>C (p.Arg261Pro)","PAH","R261P","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 11, 2019)","reviewed by expert panel","VCV000102832","12","103246653","12","102852875",102832,"108568","rs5030849","NC_000012.12:102852874:C:G"
"NM_000277.3(PAH):c.842+1G>T","PAH","","Phenylketonuria|not provided","Pathogenic(Last reviewed: Apr 9, 2019)","reviewed by expert panel","VCV000102869","12","103246592","12","102852814",102869,"108605","rs5030852","NC_000012.12:102852813:C:A"
"NM_000552.4(VWF):c.3379+1G>A","VWF","","von Willebrand disorder|not provided|Von Willebrand disease, recessive form","Pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000100257","12","6132796","12","6023630",100257,"106134","rs2363337","NC_000012.12:6023629:C:T"
"NM_001065.4(TNFRSF1A):c.362G>A (p.Arg121Gln)","TNFRSF1A","R121Q, R13Q","TNF receptor-associated periodic fever syndrome (TRAPS)|Multiple sclerosis, susceptibility to, 5|not specified|none provided|TNF receptor-associated periodic fever syndrome (TRAPS)|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)","criteria provided, conflicting interpretations","VCV000217017","12","6442643","12","6333477",217017,"213624","rs4149584","NC_000012.12:6333476:C:T"
"NM_000059.3(BRCA2):c.9302T>G (p.Leu3101Arg)","BRCA2","L3101R","Hereditary breast and ovarian cancer syndrome|none provided|Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)","criteria provided, conflicting interpretations","VCV000038230","13","32968871","13","32394734",38230,"46786","rs28897758","NC_000013.11:32394733:T:G"
"NM_004004.6(GJB2):c.148G>A (p.Asp50Asn)","GJB2","D50N","Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Sensorineural hearing loss|Hearing loss|not provided|Hystrix-like ichthyosis with deafness","Pathogenic(Last reviewed: Jun 14, 2017)","criteria provided, multiple submitters, no conflicts","VCV000017020","13","20763573","13","20189434",17020,"32059","rs28931594","NC_000013.11:20189433:C:T"
"NM_004004.6(GJB2):c.224G>A (p.Arg75Gln)","GJB2","R75Q","not provided|Autosomal recessive nonsyndromic deafness|Deafness, autosomal dominant 3a|Rare genetic deafness|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|Hereditary palmoplantar keratoderma|Palmoplantar keratoderma-deafness syndrome","Pathogenic(Last reviewed: Aug 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017027","13","20763497","13","20189358",17027,"32066","rs28931593","NC_000013.11:20189357:C:T"
"NM_004004.6(GJB2):c.148G>T (p.Asp50Tyr)","GJB2","D50Y","Keratitis-ichthyosis-deafness syndrome, autosomal dominant","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000017028","13","20763573","13","20189434",17028,"32067","rs28931594","NC_000013.11:20189433:C:A"
"NM_000059.3(BRCA2):c.9302T>A (p.Leu3101Gln)","BRCA2","L3101Q","Hereditary breast and ovarian cancer syndrome","Uncertain significance(Last reviewed: Oct 30, 2019)","criteria provided, single submitter","VCV000573951","13","32968871","13","32394734",573951,"566097","rs28897758","NC_000013.11:32394733:T:A"
"NM_000059.3(BRCA2):c.9302T>C (p.Leu3101Pro)","BRCA2","L3101P","not specified|Hereditary breast and ovarian cancer syndrome","Uncertain significance(Last reviewed: Aug 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000216263","13","32968871","13","32394734",216263,"213090","rs28897758","NC_000013.11:32394733:T:C"
"NM_006194.3(PAX9):c.76C>T (p.Arg26Trp)","PAX9","R26W","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Aug 1, 2009)","no assertion criteria provided","VCV000013774","14","37132173","14","36662968",13774,"28813","rs28933972","NC_000014.9:36662967:C:T"
"NM_001127701.1(SERPINA1):c.415G>A (p.Gly139Ser)","SERPINA1","G139S","Alpha-1-antitrypsin deficiency|PI NULL(NEWPORT)|PI Q0(NEWPORT)|PI NULL(DEVON)|PI Q0(DEVON)","Pathogenic, other(Last reviewed: Jul 15, 2016)","no assertion criteria provided","VCV000017986","14","94849160","14","94382823",17986,"33025","rs11558261","NC_000014.9:94382822:C:T"
"NM_000137.3(FAH):c.1021C>T (p.Arg341Trp)","FAH","R341W","not provided|Fumarylacetoacetase pseudodeficiency|Tyrosinemia type I","Benign/Likely benign, other(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000011868","15","80472526","15","80180184",11868,"26907","rs11555096","NC_000015.10:80180183:C:T"
"NM_000138.5(FBN1):c.247+1G>A","FBN1","","not provided|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic(Last reviewed: Jul 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000042307","15","48905206","15","48613009",42307,"51477","rs25404","NC_000015.10:48613008:C:T"
"NM_000138.4(FBN1):c.3037G>C (p.Gly1013Arg)","FBN1","G1013R","Marfan syndrome","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000016455","15","48782093","15","48489896",16455,"31494","rs140593","NC_000015.10:48489895:C:G"
"NM_207581.4(DUOXA2):c.738C>G (p.Tyr246Ter)","DUOXA2","Y246*","Thyroglobulin synthesis defect","Pathogenic(Last reviewed: Feb 1, 2008)","no assertion criteria provided","VCV000000444","15","45409472","15","45117274",444,"15483","rs4774518","NC_000015.10:45117273:C:G"
"NM_000138.4(FBN1):c.247+1G>T","FBN1","","Marfan syndrome","Pathogenic(Last reviewed: Nov 7, 2017)","no assertion criteria provided","VCV000549086","15","48905206","15","48613009",549086,"539942","rs25404","NC_000015.10:48613008:C:A"
"NM_002693.2(POLG):c.2481-7C>T","POLG","","Toe walking|none provided|POLG-Related Spectrum Disorders|Progressive sclerosing poliodystrophy|not provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000138747","15","89865091","15","89321860",138747,"142450","rs2307448","NC_000015.10:89321859:G:A"
"NM_000138.5(FBN1):c.3037G>A (p.Gly1013Arg)","FBN1","G1013R","Marfan syndrome|not provided|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic(Last reviewed: Feb 15, 2020)","criteria provided, multiple submitters, no conflicts","VCV000177648","15","48782093","15","48489896",177648,"175987","rs140593","NC_000015.10:48489895:C:T"
"NM_000138.5(FBN1):c.7540G>A (p.Gly2514Arg)","FBN1","G2514R","Marfan syndrome|Isolated thoracic aortic aneurysm|not provided|not specified|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype","Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)","criteria provided, conflicting interpretations","VCV000178034","15","48714179","15","48421982",178034,"176123","rs363811","NC_000015.10:48421981:C:T"
"NM_014249.4(NR2E3):c.119-2A>C","NR2E3","","Cone-rod dystrophy|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Goldmann-Favre syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome|Retinitis pigmentosa|NR2E3-Related Disorders|Retinal dystrophy|not provided|not specified|Horizontal nystagmus|Visual impairment|Retinal dystrophy|Abnormality of color vision","Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)","criteria provided, multiple submitters, no conflicts","VCV000191059","15","72103821","15","71811481",191059,"188865","rs2723341","NC_000015.10:71811480:A:C"
"NM_002386.3(MC1R):c.478C>T (p.Arg160Trp)","MC1R","R160W","not specified|Cutaneous malignant melanoma 5|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Skin/hair/eye pigmentation 2, red hair/fair skin|Malignant tumor of breast|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000014310","16","89986144","16","89919736",14310,"29349","rs1805008","NC_000016.10:89919735:C:T"
"NM_003361.3(UMOD):c.649T>C (p.Cys217Arg)","UMOD","C217R, C250R","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Dec 17, 2004)","no assertion criteria provided","VCV000012256","16","20359974","16","20348652",12256,"27295","rs28934583","NC_000016.10:20348651:A:G"
"NM_003361.3(UMOD):c.307G>T (p.Gly103Cys)","UMOD","G103C, G136C","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Dec 1, 2002)","no assertion criteria provided","VCV000012257","16","20360316","16","20348994",12257,"27296","rs28934584","NC_000016.10:20348993:C:A"
"NM_003361.3(UMOD):c.649T>G (p.Cys217Gly)","UMOD","C217G, C250G","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Jan 6, 2012)","no assertion criteria provided","VCV000039418","16","20359974","16","20348652",39418,"48017","rs28934583","NC_000016.10:20348651:A:C"
"NM_021615.5(CHST6):c.599T>G (p.Leu200Arg)","CHST6","L200R","not provided|Macular corneal dystrophy|Macular corneal dystrophy, type II","Pathogenic(Last reviewed: Sep 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000005075","16","75513128","16","75479230",5075,"20114","rs28937879","NC_000016.10:75479229:A:C"
"NM_000243.3(MEFV):c.442G>C","MEFV","","Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|none provided|not provided|Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2021)","criteria provided, conflicting interpretations","VCV000002542","16","3304626","16","3254626",2542,"17581","rs3743930","NC_000016.10:3254625:C:G"
"NM_001126108.2(SLC12A3):c.625C>T (p.Arg209Trp)","SLC12A3","R209W, R208W","not provided|Familial hypokalemia-hypomagnesemia","Pathogenic(Last reviewed: Jun 6, 2020)","criteria provided, single submitter","VCV000008586","16","56904031","16","56870119",8586,"23625","rs28936388","NC_000016.10:56870118:C:T"
"NM_019109.5(ALG1):c.1312C>T (p.Arg438Trp)","ALG1|EEF2KMT","R327W, R438W","Congenital disorder of glycosylation","Likely pathogenic(Last reviewed: May 25, 2017)","no assertion criteria provided","VCV000690315","16","5134799","16","5084798",690315,"678020","rs16835020","NC_000016.10:5084797:C:T"
"NM_001009944.3(PKD1):c.2180T>A (p.Leu727Gln)","PKD1","L727Q","not provided","Uncertain significance(Last reviewed: Feb 1, 2018)","criteria provided, single submitter","VCV000586255","16","2164844","16","2114843",586255,"577527","rs1616940","NC_000016.10:2114842:A:T"
"NM_001009944.3(PKD1):c.2180T>C (p.Leu727Pro)","PKD1","L727P","Polycystic kidney disease, adult type|Autosomal dominant polycystic kidney disease|not provided|Polycystic kidney disease|Polycystic kidney disease 3","Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)","criteria provided, conflicting interpretations","VCV000562302","16","2164844","16","2114843",562302,"553486","rs1616940","NC_000016.10:2114842:A:G"
"NM_004608.3(TBX6):c.1227G>A (p.Pro409=)","TBX6","","not specified|not provided","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000259448","16","30097630","16","30086309",259448,"255673","rs2289292","NC_000016.10:30086308:C:T"
"NM_000422.3(KRT17):c.296T>C (p.Leu99Pro)","KRT17","L99P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Jun 9, 2015)","criteria provided, single submitter","VCV000014598","17","39780466","17","41624214",14598,"29637","rs28933089","NC_000017.11:41624213:A:G"
"NM_005557.4(KRT16):c.383T>A (p.Leu128Gln)","KRT16","L128Q","not provided|Pachyonychia congenita 1","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000014609","17","39768558","17","41612306",14609,"29648","rs28928895","NC_000017.11:41612305:A:T"
"NM_000422.3(KRT17):c.284T>C (p.Leu95Pro)","KRT17","L95P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 14, 2015)","criteria provided, single submitter","VCV000014596","17","39780478","17","41624226",14596,"29635","rs28928899","NC_000017.11:41624225:A:G"
"NM_000422.3(KRT17):c.292T>G (p.Tyr98Asp)","KRT17","Y98D","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Feb 1, 1997)","no assertion criteria provided","VCV000014588","17","39780470","17","41624218",14588,"29627","rs28933088","NC_000017.11:41624217:A:C"
"NM_000422.3(KRT17):c.281G>A (p.Arg94His)","KRT17","R94H","not provided|Pachyonychia congenita 2|Steatocystoma multiplex","Pathogenic(Last reviewed: Dec 1, 2019)","criteria provided, single submitter","VCV000014590","17","39780481","17","41624229",14590,"29629","rs28928897","NC_000017.11:41624228:C:T"
"NM_000422.3(KRT17):c.281G>C (p.Arg94Pro)","KRT17","R94P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 1, 2001)","no assertion criteria provided","VCV000014594","17","39780481","17","41624229",14594,"29633","rs28928897","NC_000017.11:41624228:C:G"
"NM_000422.3(KRT17):c.284T>A (p.Leu95Gln)","KRT17","L95Q","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 1, 2001)","no assertion criteria provided","VCV000014595","17","39780478","17","41624226",14595,"29634","rs28928899","NC_000017.11:41624225:A:T"
"NM_000546.6(TP53):c.215C>G (p.Pro72Arg)","TP53","P72R, P33R","not specified|not provided|Li-Fraumeni syndrome|fluorouracil response - Efficacy, Toxicity/ADR|paclitaxel response - Efficacy, Toxicity/ADR|antineoplastic agents response - Efficacy, Toxicity/ADR|cisplatin response - Efficacy, Toxicity/ADR|cyclophosphamide response - Efficacy, Toxicity/ADR|Li-Fraumeni syndrome 1|CODON 72 POLYMORPHISM|none provided|Lip and oral cavity carcinoma|Hereditary cancer-predisposing syndrome","drug response(Last reviewed: Oct 17, 2016)","reviewed by expert panel","VCV000012351","17","7579472","17","7676154",12351,"27390","rs1042522","NC_000017.11:7676153:G:C"
"NM_000546.6(TP53):c.743G>A (p.Arg248Gln)","TP53","R248Q, R116Q, R209Q, R89Q","Breast neoplasm|Neoplasm|Nasopharyngeal carcinoma|Carcinoma of colon|Li-Fraumeni syndrome 1|Carcinoma of pancreas|Choroid plexus papilloma|Osteosarcoma|Glioma susceptibility 1|Familial cancer of breast|Adrenocortical carcinoma, hereditary|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Pancreatic adenocarcinoma|Multiple myeloma|Li-Fraumeni syndrome|Medulloblastoma|Chronic lymphocytic leukemia|Squamous cell carcinoma of the skin|Brainstem glioma|Transitional cell carcinoma of the bladder|Small cell lung carcinoma|Lung adenocarcinoma|Malignant melanoma of skin|Hepatocellular carcinoma|not provided|Neoplasm of ovary|Acute myeloid leukemia|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Myelodysplastic syndrome|Familial cancer of breast|Malignant Colorectal Neoplasm|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Lip and oral cavity carcinoma|Lymphoma|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Ductal carcinoma in situ|Sarcoma|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|Uterine Carcinosarcoma|Glioblastoma","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000012356","17","7577538","17","7674220",12356,"27395","rs11540652","NC_000017.11:7674219:C:T"
"NM_000018.4(ACADVL):c.194C>T (p.Pro65Leu)","ACADVL","P65L, P88L","not provided|Very long chain acyl-CoA dehydrogenase deficiency|not specified","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000038798","17","7123838","17","7220519",38798,"16670","rs28934585","NC_000017.11:7220518:C:T"
"NM_002055.5(GFAP):c.1055T>C (p.Leu352Pro)","GFAP","L352P","not provided|Alexander Disease","Pathogenic(Last reviewed: Jan 8, 2015)","no assertion criteria provided","VCV000016178","17","42988676","17","44911308",16178,"31217","rs28932769","NC_000017.11:44911307:A:G"
"NM_007294.4(BRCA1):c.3748G>T (p.Glu1250Ter)","BRCA1","E1250*, E1203*","not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial 1","Pathogenic(Last reviewed: Sep 8, 2016)","reviewed by expert panel","VCV000017672","17","41243800","17","43091783",17672,"32711","rs28897686","NC_000017.11:43091782:C:A"
"NM_000080.4(CHRNE):c.293T>C (p.Leu98Pro)","CHRNE|C17orf107","L98P","Myasthenic syndrome, congenital, 4a, slow-channel","Likely pathogenic(Last reviewed: Sep 22, 2019)","criteria provided, single submitter","VCV000534249","17","4805563","17","4902268",534249,"531399","rs28929768","NC_000017.11:4902267:A:G"
"NM_000546.5(TP53):c.329G>T (p.Arg110Leu)","TP53","R110L, R71L","Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm of ovary","Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2021)","criteria provided, multiple submitters, no conflicts","VCV000406597","17","7579358","17","7676040",406597,"402569","rs11540654","NC_000017.11:7676039:C:A"
"NM_000546.6(TP53):c.329G>A (p.Arg110His)","TP53","R110H, R71H","Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|not specified","Likely benign(Last reviewed: Aug 11, 2020)","reviewed by expert panel","VCV000127808","17","7579358","17","7676040",127808,"133265","rs11540654","NC_000017.11:7676039:C:T"
"NM_000546.5(TP53):c.215= (p.Pro72=)","TP53","","not specified","Benign(Last reviewed: Aug 15, 2013)","criteria provided, single submitter","VCV000165560","17","7579472","17","7676154",165560,"176504","rs1042522","NC_000017.11:7676153:G:G"
"NM_007294.4(BRCA1):c.3748G>A (p.Glu1250Lys)","BRCA1","E1250K, E1203K","Malignant tumor of breast|Hereditary cancer-predisposing syndrome|none provided|Breast-ovarian cancer, familial 1|Breast neoplasm|not specified|Breast and/or ovarian cancer|Hereditary breast and ovarian cancer syndrome","Benign(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000054987","17","41243800","17","43091783",54987,"69654","rs28897686","NC_000017.11:43091782:C:T"
"NM_000546.5(TP53):c.743G>C (p.Arg248Pro)","TP53","R116P, R209P, R248P, R89P","Small cell lung carcinoma|Multiple myeloma|Medulloblastoma|Hepatocellular carcinoma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Myelodysplastic syndrome|Breast neoplasm|Chronic lymphocytic leukemia|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Li-Fraumeni syndrome|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin|Acute myeloid leukemia","Pathogenic(Last reviewed: Jan 10, 2019)","criteria provided, single submitter","VCV000237954","17","7577538","17","7674220",237954,"242980","rs11540652","NC_000017.11:7674219:C:G"
"NM_000152.5(GAA):c.2238G>A (p.Trp746Ter)","GAA","W746*","not provided|Glycogen storage disease, type II","Pathogenic(Last reviewed: May 5, 2020)","reviewed by expert panel","VCV000370904","17","78090815","17","80117016",370904,"358515","rs1800312","NC_000017.11:80117015:G:A"
"NM_000152.5(GAA):c.2238G>C (p.Trp746Cys)","GAA","W746C","Glycogen storage disease, type II|not provided|Glycogen storage disease","Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000265160","17","78090815","17","80117016",265160,"260196","rs1800312","NC_000017.11:80117015:G:C"
"NM_005557.4(KRT16):c.383T>C (p.Leu128Pro)","KRT16","L128P","not provided","Pathogenic(Last reviewed: Aug 1, 2016)","criteria provided, single submitter","VCV000265486","17","39768558","17","41612306",265486,"260164","rs28928895","NC_000017.11:41612305:A:G"
"NM_000546.5(TP53):c.215C>A (p.Pro72His)","TP53","P33H, P72H","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1","Likely benign(Last reviewed: Apr 19, 2021)","reviewed by expert panel","VCV000185120","17","7579472","17","7676154",185120,"185405","rs1042522","NC_000017.11:7676153:G:T"
"NM_000546.5(TP53):c.743G>T (p.Arg248Leu)","TP53","R116L, R209L, R248L, R89L","Small cell lung carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Medulloblastoma|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Multiple myeloma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Myelodysplastic syndrome|Breast neoplasm|Chronic lymphocytic leukemia|Acute myeloid leukemia|Squamous cell carcinoma of the head and neck|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Lung adenocarcinoma|Neoplasm of brain|Brainstem glioma|Squamous cell carcinoma of the skin|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000230253","17","7577538","17","7674220",230253,"236469","rs11540652","NC_000017.11:7674219:C:A"
"NM_000546.5(TP53):c.329G>C (p.Arg110Pro)","TP53","R110P, R71P","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Sep 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000233627","17","7579358","17","7676040",233627,"236497","rs11540654","NC_000017.11:7676039:C:G"
"NM_001329877.1(FUT1):c.725T>G (p.Leu242Arg)","FUT1","L242R","BOMBAY PHENOTYPE, DIGENIC|Bombay phenotype","Pathogenic, Affects(Last reviewed: Sep 8, 1997)","no assertion criteria provided","VCV000012142","19","49253814","19","48750557",12142,"27181","rs28934588","NC_000019.10:48750556:A:C"
"NM_000540.3(RYR1):c.742G>A (p.Gly248Arg)","RYR1","G248R","not provided|Malignant hyperthermia, susceptibility to, 1|enflurane response - Toxicity/ADR|succinylcholine response - Toxicity/ADR|sevoflurane response - Toxicity/ADR|methoxyflurane response - Toxicity/ADR|isoflurane response - Toxicity/ADR|halothane response - Toxicity/ADR|desflurane response - Toxicity/ADR","drug response","reviewed by expert panel","VCV000012965","19","38937350","19","38446710",12965,"28004","rs1801086","NC_000019.10:38446709:G:A"
"NM_020956.2(PRX):c.*2156G>A","PRX","D651N","Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, demyelinating, type 4F","Uncertain significance(Last reviewed: Aug 20, 2019)","criteria provided, single submitter","VCV000038452","19","40902308","19","40396401",38452,"47011","rs3814290","NC_000019.10:40396400:C:T"
"NM_000435.3(NOTCH3):c.1363T>C (p.Cys455Arg)","NOTCH3","C455R","not provided|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: May 25, 2017)","criteria provided, single submitter","VCV000009223","19","15299815","19","15189004",9223,"24262","rs28933698","NC_000019.10:15189003:A:G"
"NM_000540.2(RYR1):c.742G>C (p.Gly248Arg)","RYR1","G248R","not provided|RYR1-Related Disorders","Pathogenic(Last reviewed: Feb 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000133203","19","38937350","19","38446710",133203,"136950","rs1801086","NC_000019.10:38446709:G:C"
"NM_000527.5(LDLR):c.939C>A (p.Cys313Ter)","LDLR","C313*, C272*, C186*, C145*","Familial hypercholesterolemia|Familial hypercholesterolemia 1","Pathogenic(Last reviewed: Jun 4, 2019)","criteria provided, multiple submitters, no conflicts","VCV000251539","19","11218189","19","11107513",251539,"245872","rs13306512","NC_000019.10:11107512:C:A"
"NM_000527.5(LDLR):c.939C>G (p.Cys313Trp)","LDLR","C313W, C145W, C272W, C186W","Familial hypercholesterolemia|Familial hypercholesterolemia 1","Conflicting interpretations of pathogenicity(Last reviewed: Aug 13, 2018)","criteria provided, conflicting interpretations","VCV000251540","19","11218189","19","11107513",251540,"245873","rs13306512","NC_000019.10:11107512:C:G"
"NM_000041.4(APOE):c.137T>C (p.Leu46Pro)","APOE","L46P, L72P","Alzheimer disease, type 4|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2021)","criteria provided, conflicting interpretations","VCV000242765","19","45411110","19","44907853",242765,"32909","rs769452","NC_000019.10:44907852:T:C"
"NM_000523.4(HOXD13):c.916C>T (p.Arg306Trp)","HOXD13","R306W","Synpolydactyly 1","Pathogenic(Last reviewed: Nov 1, 2002)","no assertion criteria provided","VCV000014872","2","176959342","2","176094614",14872,"29911","rs28933082","NC_000002.12:176094613:C:T"
"NM_001372051.1(CASP8):c.742C>T (p.Arg248Trp)","CASP8","R248W, R265W, R307W, R233W, T226M","Autoimmune lymphoproliferative syndrome type 2B","Pathogenic(Last reviewed: Sep 26, 2002)","no assertion criteria provided","VCV000007760","2","202141631","2","201276908",7760,"22799","rs17860424","NC_000002.12:201276907:C:T"
"NM_000523.4(HOXD13):c.916C>G (p.Arg306Gly)","HOXD13","R306G","Synpolydactyly 1","Pathogenic(Last reviewed: Aug 12, 2016)","no assertion criteria provided","VCV000225656","2","176959342","2","176094614",225656,"227492","rs28933082","NC_000002.12:176094613:C:G"
"NM_000308.3(CTSA):c.247T>C (p.Trp83Arg)","CTSA","W65R, W83R","Combined deficiency of sialidase AND beta galactosidase","Pathogenic(Last reviewed: Jun 1, 1993)","no assertion criteria provided","VCV000000378","20","44520400","20","45891761",378,"15417","rs28934603","NC_000020.11:45891760:T:C"
"NM_000557.5(GDF5):c.1322T>C (p.Leu441Pro)","GDF5|GDF5-AS1","L441P","Brachydactyly type A2|Fibular hypoplasia and complex brachydactyly","Pathogenic(Last reviewed: Mar 1, 2006)","no assertion criteria provided","VCV000008381","20","34021891","20","35434093",8381,"23420","rs28936683","NC_000020.11:35434092:A:G"
"NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)","KCNE1","D85N","not provided|none provided|Long QT syndrome|Cardiovascular phenotype|Congenital long QT syndrome|Cardiomyopathy|Long QT syndrome 2/5|Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Long QT syndrome 5, acquired, susceptibility to|not specified","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000013479","21","35821680","21","34449382",13479,"28518","rs1805128","NC_000021.9:34449381:C:T"
"NM_000100.4(CSTB):c.43G>T (p.Glu15Ter)","CSTB","E15*","not provided","Likely pathogenic(Last reviewed: Aug 1, 2019)","criteria provided, single submitter","VCV000809294","21","45196108","21","43776227",809294,"798031","rs11553836","NC_000021.9:43776226:C:A"
"NM_016335.6(PRODH):c.1562= (p.Arg521=)","PRODH","","Proline dehydrogenase deficiency|not provided|Schizophrenia 4","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000004010","22","18901004","22","18913491",4010,"19049","rs450046","NC_000022.11:18913490:C:C"
"NM_000387.6(SLC25A20):c.713A>G (p.Gln238Arg)","SLC25A20","Q238R","Carnitine acylcarnitine translocase deficiency|not provided","Pathogenic(Last reviewed: Dec 17, 2013)","criteria provided, multiple submitters, no conflicts","VCV000012138","3","48896530","3","48859097",12138,"27177","rs28934589","NC_000003.12:48859096:T:C"
"NM_001354712.2(THRB):c.1357C>A (p.Pro453Thr)","THRB","P453T, P422T","not provided|Thyroid hormone resistance, generalized, autosomal dominant","Pathogenic(Last reviewed: Sep 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012550","3","24164404","3","24122913",12550,"27589","rs28933408","NC_000003.12:24122912:G:T"
"NM_000551.4(VHL):c.194C>G (p.Ser65Trp)","VHL","S65W","not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jul 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000043597","3","10183725","3","10142041",43597,"52766","rs5030826","NC_000003.12:10142040:C:G"
"NM_000335.5(SCN5A):c.1673A>G (p.His558Arg)","SCN5A","H558R","Arrhythmia|not specified|not provided|Brugada syndrome|Congenital long QT syndrome|Cardiovascular phenotype|Brugada syndrome 1|none provided|Paroxysmal familial ventricular fibrillation 1|Sick sinus syndrome 1, autosomal recessive|Progressive familial heart block, type 1A|Dilated cardiomyopathy 1E|Long QT syndrome 3","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000048289","3","38645420","3","38603929",48289,"38447","rs1805124","NC_000003.12:38603928:T:C"
"NM_003907.3(EIF2B5):c.1882T>C (p.Trp628Arg)","EIF2B5","W628R","Leukoencephalopathy with vanishing white matter","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000005943","3","183861899","3","184144111",5943,"20982","rs28937596","NC_000003.12:184144110:T:C"
"NM_000404.2(GLB1):c.367G>A","GLB1","G123R, G171R, G93R","Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Infantile GM1 gangliosidosis|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2019)","criteria provided, multiple submitters, no conflicts","VCV000000928","3","33110341","3","33068849",928,"15967","rs28934274","NC_000003.12:33068848:C:T"
"NM_000551.3(VHL):c.499C>T (p.Arg167Trp)","VHL|LOC107303340","R167W, R126W","Von Hippel-Lindau syndrome|Pheochromocytoma|Renal cell carcinoma, nonpapillary|Erythrocytosis, familial, 2|Pheochromocytoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Renal cell carcinoma, papillary, 1|not provided|Hereditary cancer-predisposing syndrome|none provided","Pathogenic(Last reviewed: Sep 16, 2020)","criteria provided, multiple submitters, no conflicts","VCV000002218","3","10191506","3","10149822",2218,"17257","rs5030820","NC_000003.12:10149821:C:T"
"NM_000551.3(VHL):c.499C>G (p.Arg167Gly)","VHL|LOC107303340","R167G, R126G","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000002219","3","10191506","3","10149822",2219,"17258","rs5030820","NC_000003.12:10149821:C:G"
"NM_198056.2(SCN5A):c.4931G>A (p.Arg1644His)","SCN5A","R1644H, R1643H, R1590H, R1611H, R1625H, R1626H","Congenital long QT syndrome|Long QT syndrome 3|not provided|Brugada syndrome|Cardiovascular phenotype","Pathogenic(Last reviewed: Mar 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009369","3","38592932","3","38551441",9369,"24408","rs28937316","NC_000003.12:38551440:C:T"
"NM_198056.2(SCN5A):c.1100G>A (p.Arg367His)","SCN5A","R367H","Brugada syndrome|Brugada syndrome 1|Arrhythmia","Pathogenic(Last reviewed: Jul 15, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009390","3","38648200","3","38606709",9390,"24429","rs28937318","NC_000003.12:38606708:C:T"
"NM_198056.2(SCN5A):c.3893C>T (p.Pro1298Leu)","SCN5A","P1298L, P1297L, P1244L","Sick sinus syndrome|Arrhythmia|Sick sinus syndrome 1, autosomal recessive","Uncertain significance(Last reviewed: Dec 10, 2018)","criteria provided, single submitter","VCV000009394","3","38603976","3","38562485",9394,"24433","rs28937319","NC_000003.12:38562484:G:A"
"NM_001354712.2(THRB):c.1357C>G (p.Pro453Ala)","THRB","P453A, P422A","not provided|Thyroid hormone resistance, generalized, autosomal dominant","Pathogenic(Last reviewed: Dec 13, 2019)","criteria provided, single submitter","VCV000492924","3","24164404","3","24122913",492924,"485714","rs28933408","NC_000003.12:24122912:G:C"
"NM_000551.3(VHL):c.533T>C (p.Leu178Pro)","VHL|LOC107303340","L178P, L137P","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, multiple submitters, no conflicts","VCV000428795","3","10191540","3","10149856",428795,"420453","rs5030822","NC_000003.12:10149855:T:C"
"NM_001354712.2(THRB):c.1357C>T (p.Pro453Ser)","THRB","P453S, P422S","not provided|Thyroid hormone resistance, generalized, autosomal dominant","Pathogenic(Last reviewed: Nov 19, 2016)","criteria provided, single submitter","VCV000439310","3","24164404","3","24122913",439310,"432550","rs28933408","NC_000003.12:24122912:G:A"
"NM_000551.3(VHL):c.533T>A (p.Leu178Gln)","VHL|LOC107303340","L178Q, L137Q","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625260","3","10191540","3","10149856",625260,"613591","rs5030822","NC_000003.12:10149855:T:A"
"NM_000551.3(VHL):c.533T>G (p.Leu178Arg)","VHL|LOC107303340","L178R, L137R","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625261","3","10191540","3","10149856",625261,"613592","rs5030822","NC_000003.12:10149855:T:G"
"NM_000335.4(SCN5A):c.1100G>T (p.Arg367Leu)","SCN5A","R367L","Brugada syndrome","not provided","no assertion provided","VCV000067634","3","38648200","3","38606709",67634,"78530","rs28937318","NC_000003.12:38606708:C:A"
"NM_000551.3(VHL):c.194C>T (p.Ser65Leu)","VHL","S65L","Pancreatic cysts|Cerebellar hemangioblastoma|Retinal capillary hemangioma|Spinal hemangioblastoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Pathogenic(Last reviewed: Jun 16, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182975","3","10183725","3","10142041",182975,"180112","rs5030826","NC_000003.12:10142040:C:T"
"NM_000551.3(VHL):c.194C>A (p.Ser65Ter)","VHL","S65*","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Sep 23, 2019)","criteria provided, single submitter","VCV000223161","3","10183725","3","10142041",223161,"224892","rs5030826","NC_000003.12:10142040:C:A"
"NM_002448.3(MSX1):c.251A>T (p.Glu84Val)","MSX1","E84V","Orofacial cleft 5","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000014883","4","4861877","4","4860150",14883,"29922","rs28928890","NC_000004.12:4860149:A:T"
"NM_003102.3(SOD3):c.691C>G (p.Arg231Gly)","SOD3","R213G, R231G","Superoxide dismutase, elevated extracellular","Pathogenic(Last reviewed: Jan 6, 2004)","no assertion criteria provided","VCV000012777","4","24801834","4","24800212",12777,"27816","rs1799895","NC_000004.12:24800211:C:G"
"NM_000142.5(FGFR3):c.1172C>A (p.Ala391Glu)","FGFR3","A391E, A393E","not provided|Craniosynostosis syndrome|Inborn genetic diseases|Carcinoma|Crouzon syndrome with acanthosis nigricans","Pathogenic(Last reviewed: Oct 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000016329","4","1806153","4","1804426",16329,"31368","rs28931615","NC_000004.12:1804425:C:A"
"NM_002099.8(GYPA):c.232G>A (p.Gly78Arg)","GYPA","G78R, G45R, E78K","BLOOD GROUP ERIK","Pathogenic(Last reviewed: Dec 5, 1993)","no assertion criteria provided","VCV000017714","4","145040839","4","144119686",17714,"32753","rs1800582","NC_000004.12:144119685:C:T"
"NM_022965.3(FGFR3):c.931-398C>T","FGFR3","A391V, A393V","not provided","Uncertain significance(Last reviewed: Aug 1, 2017)","criteria provided, single submitter","VCV000809609","4","1806153","4","1804426",809609,"795565","rs28931615","NC_000004.12:1804425:C:T"
"NM_000038.6(APC):c.1458T>C (p.Tyr486=)","APC","","Hereditary cancer-predisposing syndrome|APC-Associated Polyposis Disorders|Familial adenomatous polyposis 1|not specified|Carcinoma of colon|Hepatocellular carcinoma|Carcinoma of colon|Neoplasm of stomach|Familial adenomatous polyposis 1|Desmoid disease, hereditary|Familial colorectal cancer","Benign(Last reviewed: Dec 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000042238","5","112162854","5","112827157",42238,"51408","rs2229992","NC_000005.10:112827156:T:C"
"NM_000521.3(HEXB):c.185C>T (p.Ser62Leu)","HEXB","","Sandhoff disease, infantile type|Sandhoff disease","Benign(Last reviewed: Dec 8, 2020)","criteria provided, single submitter","VCV000003882","5","73981270","5","74685445",3882,"18921","rs820878","NC_000005.10:74685444:T:T"
"NM_000038.6(APC):c.1458T>G (p.Tyr486Ter)","APC","Y486*, Y468*, Y458*, Y203*, Y360*, Y385*, Y395*, Y427*, Y326*, Y445*, Y461*, Y496*, Y504*","Familial adenomatous polyposis 1","Pathogenic(Last reviewed: Mar 2, 2019)","criteria provided, single submitter","VCV000000825","5","112162854","5","112827157",825,"15864","rs2229992","NC_000005.10:112827156:T:G"
"NM_004168.4(SDHA):c.1660C>T (p.Arg554Trp)","SDHA","R554W, R506W","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Mitochondrial complex II deficiency, nuclear type 1|Hereditary cancer-predisposing syndrome|Leigh syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)","criteria provided, conflicting interpretations","VCV000008742","5","251215","5","251100",8742,"23781","rs9809219","NC_000005.10:251099:C:T"
"NM_000521.4(HEXB):c.185T>C (p.Leu62Ser)","HEXB","L62S","not specified|Sandhoff disease","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000167173","5","73981270","5","74685445",167173,"177767","rs820878","NC_000005.10:74685444:T:C"
"NM_000500.9(CYP21A2):c.713T>A (p.Val238Glu)","CYP21A2|LOC106780800","V238E, V103E, V208E","not provided","Pathogenic(Last reviewed: May 23, 2017)","criteria provided, single submitter","VCV000012173","6","32007587","6","32039810",12173,"27212","rs12530380","NC_000006.12:32039809:T:A"
"NM_000500.9(CYP21A2):c.1069C>T (p.Arg357Trp)","CYP21A2|TNXB|LOC106780800","R357W, R327W, R222W","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Aug 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012152","6","32008312","6","32040535",12152,"27191","rs7769409","NC_000006.12:32040534:C:T"
"NM_000420.3(KEL):c.1790T>C (p.Leu597Pro)","KEL","L597P","not provided|Kel6 antigen","Benign(Last reviewed: May 4, 2017)","criteria provided, single submitter","VCV000031082","7","142640113","7","142943026",31082,"40039","rs8176038","NC_000007.14:142943025:A:G"
"NM_000941.3(POR):c.1475T>A (p.Val492Glu)","POR","V492E","Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis","Pathogenic(Last reviewed: Mar 1, 2004)","no assertion criteria provided","VCV000016901","7","75614973","7","75985655",16901,"31940","rs28931606","NC_000007.14:75985654:T:A"
"NM_001098629.3(IRF5):c.-12+198=","IRF5","","Systemic lupus erythematosus 10|Rheumatoid arthritis","Pathogenic, risk factor(Last reviewed: Mar 15, 2008)","no assertion criteria provided","VCV000003396","7","128578301","7","128938247",3396,"18435","rs2004640","NC_000007.14:128938246:T:T"
"NM_003995.3(NPR2):c.343T>G (p.Trp115Gly)","NPR2","W115G","Acromesomelic dysplasia, Maroteaux type","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000017785","9","35792748","9","35792751",17785,"32824","rs28931582","NC_000009.12:35792750:T:G"
"NM_001701.4(BAAT):c.226A>G (p.Met76Val)","BAAT","M76V","Bile acid conjugation defect 1","Pathogenic(Last reviewed: May 1, 2003)","no assertion criteria provided","VCV000006720","9","104133461","9","101371179",6720,"21759","rs28937579","NC_000009.12:101371178:T:C"
"NM_000402.4(G6PD):c.1093G>A (p.Ala365Thr)","G6PD","A335T, A365T","Susceptibility to malaria|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD CHATHAM|not provided|Inborn genetic diseases","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000010363","X","153761205","X","154532990",10363,"25402","rs5030869","NC_000023.11:154532989:C:T"
"NM_000132.3(F8):c.5533A>C (p.Thr1845Pro)","F8","T1845P","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jul 1, 1992)","no assertion criteria provided","VCV000010282","X","154133139","X","154904864",10282,"25321","rs28933676","NC_000023.11:154904863:T:G"
"NM_000054.6(AVPR2):c.337C>T (p.Arg113Trp)","AVPR2","R113W","Nephrogenic diabetes insipidus, X-linked","Pathogenic(Last reviewed: May 27, 1993)","no assertion criteria provided","VCV000010840","X","153171297","X","153905843",10840,"25879","rs28935496","NC_000023.11:153905842:C:T"
"NM_000381.4(MID1):c.1877T>C (p.Leu626Pro)","MID1","L626P, L588P","Opitz GBBB syndrome, type I","Pathogenic(Last reviewed: Oct 12, 2000)","no assertion criteria provided","VCV000010808","X","10417535","X","10449495",10808,"25847","rs28934611","NC_000023.11:10449494:A:G"
"NM_004463.3(FGD1):c.1829G>A (p.Arg610Gln)","FGD1","R610Q","not provided|Aarskog syndrome","Pathogenic(Last reviewed: Mar 30, 2016)","criteria provided, single submitter","VCV000010825","X","54482666","X","54456233",10825,"25864","rs28935497","NC_000023.11:54456232:C:T"
"NM_139058.3(ARX):c.98T>C (p.Leu33Pro)","ARX","L33P","Mental retardation, with or without seizures, ARX-related, X-linked","Pathogenic(Last reviewed: Apr 15, 2002)","no assertion criteria provided","VCV000011198","X","25033757","X","25015640",11198,"26237","rs28936077","NC_000023.11:25015639:A:G"
